Abstract:Background Lipoprotein lipase (LPL) deficiency, the most common familial chylomicronemia syndrome (FCS), is a rare autosomal recessive disease characterized by chylomicronemia and severe hypertriglyceridemia (HTG), with limited clinical and genetic characterization. Objective To describe the manifestations and management of 19 pediatric patients with LPL-FCS. Methods LPL-FCS patients from 2014 to 2022 were divided into low-fat (LF), very-low-fat (VLF) and medium-chain-triglyceride (MCT) groups. Their clinical data were evaluated to investigate the effect of different diets. The genotype-phenotype relationship was assessed. Linear regression comparing long-chain triglyceride (LCT) intake and TG levels was analyzed. Results Nine novel LPL variants were identified in 19 LPL-FCS pediatric patients. At baseline, eruptive xanthomas occurred in 3/19 patients, acute pancreatitis in 2/19, splenomegaly in 6/19 and hepatomegaly in 3/19. The median triglyceride (TG) level (30.3mmol/L) was markedly increased. The MCT group and VLF group with LCT intakes <20 en% (energy percentage) had considerably lower TG levels than the LF group (both p <0.05). The LF group presented with severe HTG and significantly decreased TG levels after restricting LCT intakes to <20 en% ( p <0.05). Six infants decreased TG levels to <10 mmol/L by keeping LCT intake <10 en%. TG levels and LCT intake were positively correlated in both patients under 2 years (r=0.84) and those aged 2-9 years (r=0.89). No genotype-phenotype relationship was observed. Conclusions This study broadens the clinical and genetic spectra of LPL-FCS. The primary therapy for LPL-FCS pediatric patients is restricting dietary LCTs to <10 en% or <20 en% depending on different ages. MCTs potentially provide extra energy. Abbreviations : AP, acute pancreatitis; apo, apolipoprotein; ACMG, American College of Medical Genetics and Genomics; apo, apolipoprotein; BMI, body mass index; en%, energy percentage; E, exon; ES, exome sequencing; FCS, familial chylomicronemia syndrome; GPIHBP1, glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1; HTG, hypertriglyceridemia; HEK, human embryonic kidney; HDL-C, high-density lipoprotein cholesterol; IQR, interquartile ranges; kcal, kilocalorie; LPL, lipoprotein lipase; LF, low fat; LCT, long-chain triglyceride; LMF1, lipase maturation factor 1; LDL-C, low-density lipoprotein cholesterol; LP, likely pathogenic; MCT, medium-chain triglyceride; MCS, multifactorial chylomicronemia syndrome; P, pathogenic; qPCR, quantitative polymerase chain reaction; SDS, standard deviation score; SD, standard deviation; TC, total cholesterol; TG, triglyceride; VLF, very low fat

Plasma Exchange Therapy for Familial Chylomicronemia Syndrome in Infant: A Case Report

Clinical, Biochemical and Molecular Analysis of Two Infants with Familial Chylomicronemia Syndrome.

Exchange Transfusion: A Good Option for the Acute Treatment of Familial Chylomicronemia Syndrome in the Neonatal Period

Analysis of a Chinese Pedigree With Familial Chylomicronemia Syndrome Reveals Two Novel LPL Mutations by Whole-Exome Sequencing.

Chinese patient with cerebrotendinous xanthomatosis confirmed by genetic testing: A case report and literature review.

Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene

Clinical Profile, Genetic Spectrum and Therapy Evaluation of 19 Chinese Pediatric Patients with Lipoprotein Lipase Deficiency

Comparison of patients with familial chylomicronemia syndrome and multifactorial chylomicronemia syndrome

Infantile cholestasis caused by CFTR mutation: case report and literature review

Development of a Clinical Diagnostic Score for Familial Chylomicronemia Syndrome (FCS)

Effects of Plasma Exchange Combined with Continuous Renal Replacement Therapy on Acute Fatty Liver of Pregnancy.

Acute coronary syndrome in an 8-year-old child with familial hypercholesterolemia: a case report

Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry

Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in Triglycerides

Genetic analysis and management of a familial hypercholesterolemia pedigree with polygenic variants: Case report

Familial Hemophagocytic Lymphohistiocytosis in a Premature Low Birth Weight Infant: a Rare Case Report

Plasma exchange can be an alternative therapeutic modality for severe cytokine release syndrome after chimeric antigen receptor-T cell infusion: a case report.

A girl with a novel nonsense mutation in Chediak-Higashi syndrome was relieved successfully by treatment with HCST and UCBT: a case report

Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia – Case Report and Literature Review

Successful treatment of an infant with congenital bile acid synthesis disorder type 3 by ursodeoxycholic acid: a case report

Therapeutic Plasma Exchange for a Critically Ill Late Preterm Infant with Multisystem Inflammatory Syndrome of Children: A Case Report and Review of the Literature